EN
抗体药类似物
Research Grade Lifastuzumab
All
  • CatalogTD-HF574016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsDNIB0600A(conjugate),MNIB2126A(nonconjugate),CAS:1615697-16-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Lifastuzumab


Catalog No. TD-HF574016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Sodium/phosphate cotransporter 2B, Na(+)-dependent phosphate cotransporter 2B, Na(+)/Pi cotransporter 2B, Sodium-dependent phosphate transport protein 2B, NaPi3b, NaPi-2b, SLC34A2, Solute carrier family 34 member 2, Sodium-phosphate transport protein 2B
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O95436
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names DNIB0600A(conjugate),MNIB2126A(nonconjugate),CAS:1615697-16-9
Background Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity.
Note For research use only. Not for use in clinical or therapeutic applications.